Lauren Cobb

708 total citations
30 papers, 353 citations indexed

About

Lauren Cobb is a scholar working on Reproductive Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lauren Cobb has authored 30 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Reproductive Medicine, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Lauren Cobb's work include Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Lauren Cobb is often cited by papers focused on Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Lauren Cobb collaborates with scholars based in United States, Germany and France. Lauren Cobb's co-authors include David M. Gershenson, Kimberly Levinson, Titilope Oduyebo, Stuart A. Grossman, Anna F. Piotrowski, Rebecca L. Stone, Kara Long Roche, Amanda N. Fader, Edward J. Tanner and Xiangrong Kong and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Lauren Cobb

28 papers receiving 349 citations

Peers

Lauren Cobb
Lauren Cobb
Citations per year, relative to Lauren Cobb Lauren Cobb (= 1×) peers Tony Bonaventura

Countries citing papers authored by Lauren Cobb

Since Specialization
Citations

This map shows the geographic impact of Lauren Cobb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Cobb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Cobb more than expected).

Fields of papers citing papers by Lauren Cobb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Cobb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Cobb. The network helps show where Lauren Cobb may publish in the future.

Co-authorship network of co-authors of Lauren Cobb

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Cobb. A scholar is included among the top collaborators of Lauren Cobb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Cobb. Lauren Cobb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Previs, Rebecca A., Bryan Fellman, Jean Siedel, et al.. (2025). Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression. Gynecologic Oncology. 194. 112–118. 1 indexed citations
2.
Yang, Xue, Reid T. Powell, Clifford Stephan, et al.. (2025). Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor models. Gynecologic Oncology. 201. 152–159.
3.
Podder, Vivek, Rachel N. Grisham, Robert L. Coleman, et al.. (2025). Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment. International Journal of Gynecological Cancer. 35(12). 101938–101938. 2 indexed citations
4.
How, Jeffrey, Michael Frumovitz, Shannon N. Westin, et al.. (2024). CDK4/6 inhibitors potently inhibit cell viability in pre-clinical models of adult-type ovarian granulosa cell tumors. Gynecologic Oncology. 190. S189–S190.
5.
Westin, Shannon N., Victoria Michael, Bryan Fellman, et al.. (2023). Now: Neoadjuvant Olaparib window trial in patients with newly diagnosed BRCA mutant ovarian cancer (LBA 1). Gynecologic Oncology. 176. S2–S3. 6 indexed citations
6.
Cobb, Lauren & David M. Gershenson. (2023). Novel therapeutics in low-grade serous ovarian cancer. International Journal of Gynecological Cancer. 33(3). 377–384. 12 indexed citations
7.
Messick, Craig, Andrea Milbourne, Ming Guo, et al.. (2022). A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiology Biomarkers & Prevention. 31(12). 2185–2191. 1 indexed citations
8.
Gershenson, David M., Charlotte C. Sun, Shannon N. Westin, et al.. (2022). The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes. Gynecologic Oncology. 165(3). 560–567. 31 indexed citations
9.
Gershenson, David M., Lauren Cobb, Shannon N. Westin, et al.. (2022). Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival. Gynecologic Oncology. 167(2). 139–145. 5 indexed citations
10.
Chelariu-Raicu, Anca, Lauren Cobb, & David M. Gershenson. (2021). Fertility preservation in rare ovarian tumors. International Journal of Gynecological Cancer. 31(3). 432–441. 6 indexed citations
11.
Cobb, Lauren, Sharareh Siamakpour‐Reihani, Dadong Zhang, et al.. (2021). Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecologic Oncology. 163(2). 320–326. 10 indexed citations
12.
Fleming, Nicole D., Shannon N. Westin, Larissa A. Meyer, et al.. (2020). Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. International Journal of Gynecological Cancer. 31(1). 92–97. 7 indexed citations
13.
Siamakpour‐Reihani, Sharareh, Lauren Cobb, Chen Jiang, et al.. (2020). Differential expression of immune related genes in high-grade ovarian serous carcinoma. Gynecologic Oncology. 156(3). 662–668. 3 indexed citations
14.
Schwartz, Amanda, Gloria Broadwater, Lauren Cobb, et al.. (2019). Reduction in opioid use and postoperative pain scores after elective laparotomy with implementation of enhanced recovery after surgery protocol on a gynecologic oncology service. International Journal of Gynecological Cancer. 29(5). 935–943. 24 indexed citations
15.
Cobb, Lauren, Revathy B. Iyer, Alpa M. Nick, et al.. (2019). The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance. Gynecologic Oncology. 154. 241–242. 1 indexed citations
16.
Cobb, Lauren & David M. Gershenson. (2018). Treatment of Rare Epithelial Ovarian Tumors. Hematology/Oncology Clinics of North America. 32(6). 1011–1024. 19 indexed citations
17.
Chambers, Laura, Chad M. Michener, Kimberly Levinson, et al.. (2017). Compliance with research standards within gynecologic oncology fellowship: A Gynecologic Oncology Fellowship Research Network (GOFRN) study. Gynecologic Oncology. 146(3). 647–652. 3 indexed citations
18.
Cobb, Lauren, Stéphanie Gaillard, Yihong Wang, Ie−Ming Shih, & Angeles Alvarez Secord. (2015). Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms. PubMed. 2(1). 1–1. 18 indexed citations
19.
Oduyebo, Titilope, Lauren Cobb, Xiangrong Kong, et al.. (2015). Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecologic Oncology. 140(1). 76–82. 125 indexed citations
20.
Díaz-Montes, Teresa, et al.. (2012). Introduction of Checklists at Daily Progress Notes Improves Patient Care Among the Gynecological Oncology Service. Journal of Patient Safety. 8(4). 189–193. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026